Assessment of "grading" with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy

Journal of Cellular Physiology

Volumn 221, Issue 2, 2009, Pages 343-349

  Tomasino, Rosa M ^a   Morello, Vincenza ^a   Gullo, Arianna ^a   Pompei, Giancarlo ^a   Agnese, Valentina ^a   Russo, Antonio ^a   Rinaldi, Gaetana ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; STEM CELL FACTOR; MONOCLONAL ANTIBODY; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST DISEASE; BREAST HYPERPLASIA; CANCER GRADING; CELL DAMAGE; CLINICAL EVALUATION; COLUMNAR CELL HYPERPLASIA; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DISEASE COURSE; DISEASE SURVEILLANCE; EXCISION; FEMALE; FLAT EPITHELIAL ATYPIA; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; USUAL DUCTAL HYPERPLASIA; BIOPSY; BREAST; EPITHELIUM CELL; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BIOPSY; BREAST; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 70149117793     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21858     Document Type: Article

References (47)

1. Biermann K, Göke F, Nettersheim D, Eckert D, Zhou H, Kahl P, Gashaw I, Schorle H, Büttner R. 2007. c-kit is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma. J Pathol 213:311-318. (Pubitemid 350074021)
2. Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG. 1993. Prognostic significance of benign proliferative breast disease. Cancer 71:3896-3907. (Pubitemid 23172967)
3. Boecker W. 2006. Preneoplasia of the breast. A new conceptual approach to proliferative breast disease, Vol.18. Munich: Saunders. pp 369-376.
4. Bonnett M, Wallis T, Rossmann M, Carolin K, Visscher D. 2002. Histologic analysis of atypia diagnosed on needle core breast biopsies. Mod Pathol 15:29A-30A (abstract).
5. Brogi E, Tan LK. 2002. Findings at excisional biopsy (EBX) performed after identification of columnar cell change (CCC) of ductal epithelium in breast core biopsy (CBX). Mod Pathol 15:29A-30A (abstract).
6. Chui X, Egami H, Yamashita J, Kurizaki T, Ohmachi H, Yamamoto S, Ogawa M. 1996. Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues. Br J Cancer 73:1233-1236. (Pubitemid 26162338)
7. Diallo R, Rody A, Jackisch C, Ting E, Schaefer KL, Kissler S, Karn T, Geddert H, Engels K, Kaufmann M, Gabbert HE, Shroyer KR, Poremba C. 2006. C-Kit expression in ductal carcinoma in situ of the breast: Co-expression with HER-2/neu. Hum Pathol 37:205-211. (Pubitemid 43099841)
8. Fraser JL, Raza S, Chorny K, Connolly JL, Schnitt SJ. 1998. Columnar alteration with prominent apical snouts and secretions: A spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 22:1521-1527. (Pubitemid 28550647)
9. Goldstein NS, O'Malley BA. 1997. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: A lesion associated with tubular carcinoma. Am J Clin Pathol 107:561-566.
10. Guerra-Wallace MM, Christensen WN, White RL, Jr. 2004. A retrospective study of columnar alteration with prominent apical snouts and secretions and the association with cancer. Am J Surg 188:395-398.
11. Hsu SM, Raine L, Fanger H. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580. (Pubitemid 11147380)
12. Jacobs TW, Connolly JL, Schnitt SJ. 2002. Nonmalignant lesions in breast core needle biopsies: To excise or not to excise? Am J Surg Pathol 26:1095-1110 (review).
13. Jensen KC, Kong CS. 2007. Cytologic diagnosis of columnar-cell lesions of the breast. Diagn Cytopathol 35:73-79. (Pubitemid 46247136)
14. Ko CD, Kim JS, Ko BG, Son BH, Kang HJ, Yoon HS, Cho EY, Gong G, Ahn SH. 2003. The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium. Clin Exp Metastasis 20:593-597. (Pubitemid 37463896)
15. Kunju LP, Kleer CG. 2006. Significance of flat epithelial atypia (FEA) on mammotome core needle biopsy: Should it be excised? Mod Pathol 19:32a (abstract).
16. Kunju LP, Kleer CG. 2007. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised? Hum Pathol 38:35-41.
17. Lassam N, Bickford S. 1992. Loss of c-kit expression in cultured melanoma cells. Oncogene 7:51-56.
18. Martel M, Barron-Rodriguez P, Tolgay Ocal I, Dotto J, Tavassoli FA. 2007. Flat DIN 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992-1999). Virchows Arch 451:883-891.
19. Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, Seto M, Seito T, Sugiura T, Ariyoshi Y, Takahashi T. 1993. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol 142:339-346. (Pubitemid 23026936)
20. Moinfar F, Man YG, Bratthauer GL, Ratschek M, Tavassoli FA. 2000. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (clinging ductal carcinoma in situ): A simulator of normal mammary epithelium. Cancer 88:2072-2081. (Pubitemid 30233209)
21. Nasser SM. 2004. Columnar cell lesions: Current classification and controversies. Semin Diagn Pathol 21:18-24. (Pubitemid 38327931)
22. Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A. 1992a. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res 52:6139-6143.
23. Natali PG, Nicotra MR, Sures I, Mottolese M, Botti C, Ullrich A. 1992b. Breast cancer is associated with loss of the c-kit oncogene product. Int J Cancer 52:713-717.
24. Nocka K, Majumder S, Chabot B, Ray P, Cervone M, Bernstein A, Besmer P. 1989. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-kit kinase in mutant mice. Genes Dev 3:816-826.
25. Noel JC, Fayt I, Fernandez-Aguilar S, Buxant F, Boutemy R. 2006. Proliferating activity in columnar cell lesions of the breast. Virchows Arch 449:617-621. (Pubitemid 44832631)
26. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC. 1998. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 90:697-703. (Pubitemid 28222144)
27. O'Malley FP, Mohsin SK, Badve S, Bose S, Collins LC, Ennis M, Kleer CG, Pinder SE, Schnitt SJ. 2006. Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol 19:172-179. (Pubitemid 43117601)
28. Palazzo JP, Hyslop T. 1998. Hyperplastic ductal and lobular lesions and carcinoma in situ of the breast: Reproducibility of current diagnostic criteria among community and academic based pathologists. Breast J 4:230-237. (Pubitemid 28367187)
29. Palli D, Galli M, Bianchi S, Bussolati G, Di Palma S, Eusebi V, Gambacorta M, Rosselli Del Turco M. 1996. Reproducibility of histological diagnosis of breast lesions: Results of a panel in Italy. Eur J Cancer 32A:603-607. (Pubitemid 26153737)
30. Plummer H III, Carlett J, Leftwich J, Armstrong B, Carlson P, Huff T, Krystal G. 1993. C-myc expression correlates with suppression of c-kit proto-oncogene c-kit expression in small cell lung cancer cell lines. Cancer Res 53:4337-4342. (Pubitemid 24146787)
31. Polat A. 2007. c-Kit expression in columnar cell lesions of the breast accompanied by benign and malignant breast diseases. Pathol Res Pract 203:765-769. (Pubitemid 47543534)
32. Rosai J. 1991. Borderline epithelial lesions of the breast. Am J Surg Pathol 15:209-221.
33. Rosen PP. 1999. Breast pathology: Diagnosis by needle core biopsy. Philadelphia, PA: Lippincott Williams & Wilkins.
34. Rosen PP. 2001. Rosen's breast pathology. Philadelphia, PA: Lippincott Williams & Wilkins.
35. Schnitt SJ. 2003. The diagnosis and management of pre-invasive breast disease. Flat epithelial atypia-classification, pathologic features and clinical significance. Breast Cancer Res 5:263-268.
36. Schnitt SJ, Vincent-Salomon A. 2003. Columnar cell lesions of the breast. Adv Anat Pathol 10:113-124.
37. Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R, Page DL. 1992. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 16:1133-1143. (Pubitemid 23004420)
38. Simon R, Panussis S, Maurer R, Spichtin H, Glatz K, Tapia C, Mirlacher M, Rufle A, Torhorst J, Sauter G. 2004. KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. Clin Cancer Res 10:178-183. (Pubitemid 38114177)
39. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR. 2005. Columnar cell lesions of the breast: The missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29:734-746. (Pubitemid 40734423)
40. Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Coleman D, Connolly CE, Dervan P, Eusebi V, De Miguel C, Drijkoningen M, Elston CW, Faverley D, Gad A, Jacquemier J, Lacerda M, Martinez-Penuela J, Munt C, Peterse JL, Rank F, Sylvan M, Tsakraklides V, Zafrani B. 1998. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. Commission working group on breast screening pathology. Hum Pathol 29:1056-1062. (Pubitemid 28467523)
41. Tan PH, Ho BC-S, Selvarajan S, Yap WM, Hanby A. 2005. Pathologic diagnosis of columnar cell lesions of the breast: Are there issues of reproducibility? J Clin Pathol 58:705-709.
42. Tavassoli FA. 1998. Ductal carcinoma in situ: Introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 11:140-154.
43. Tavassoli FA, Devilee P. 2003. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press. pp 10-11.
44. Tian Q, Frierson HF, Krystal GW, Moskaluk CA. 1999. Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 154:1643-1647. (Pubitemid 29262845)
45. Tsuda H, Morita D, Kimura M, Shinto E, Ohtsuka Y, Matsubara O, Inazawa J, Tamaki K, Mochizuki H, Tamai S, Hiraide H. 2005. Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation. Cancer Sci 96:48-53. (Pubitemid 40310025)
46. Tsuura Y, Suzuki T, Honma K, Sano M. 2002. Expression of c-kit protein in proliferative lesions of human breast: Sexual difference and close association with phosphotyrosine status. J Cancer Res Clin Oncol 128:239-246. (Pubitemid 34591581)
47. Ulivi P, Zoli W, Medri L, Amadori D, Saragoni L, Barbanti F, Calistri D, Silvestrini R. 2004. Ckit and SCF expression in normal and tumor breast tissue. Breast Cancer Res Treat 83:33-42. (Pubitemid 38141891)